CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kedem Pharmaceuticals Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kedem Pharmaceuticals Inc
Suite 1023, 409 Granville Street
Phone: (604) 324-4844p:604 324-4844 VANCOUVER, BC  V6C 1T2  Canada
On 9/30/2014, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Kedem Pharmaceuticals Inc. for failure to make required periodic filings with the Commission
This company is no longer actively traded on any major stock exchange.
Business Summary
Kedem Pharmaceuticals Inc., formerly Global Health Ventures Inc., is a development stage specialty pharmaceutical company engaged in developing platform technology that delivers drugs via the sublingual (under the tongue) route. The Company is also developing oral formulations of drugs, which are focused to cause fewer stomach side effects than formulations of such drugs. Its lifestyle products are related to male sexual enhancement, anti-addiction and energy boosters. The Company's therapeutic products are related to weight loss and pulmonary disease management. The Company's portfolio of products includes X-Excite (male sexual enhancement drug); Relax-B (anti-stress drug); Nico-Z (nicotine replacement product); V-Energy (energy booster product), and T-Slim (appetite suppressor drug).
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
11/30/20125/31/2012YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
7819 Services allied to motion picture production
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director ChristianBezy 57 1/7/2013 5/14/2009

Business Names
Business Name
Acting Scout Inc.
Global Health Ventures Inc.
Global Health Ventures Inc.(NDA)
Goldtown Investments Corp.

General Information
Stock Exchange: OTC


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023